dc.date.accessioned2022-01-18T19:34:35Z
dc.date.available2022-01-18T19:34:35Z
dc.date.created2022-01-18T19:34:35Z
dc.date.issued2011
dc.identifierhttps://hdl.handle.net/20.500.12866/11034
dc.identifierhttps://doi.org/10.1183/09031936.00015411
dc.description.abstractTuberculosis (TB) remains a global health pandemic. Infection is spread by the aerosol route and Mycobacterium tuberculosis must drive lung destruction to be transmitted to new hosts. Such inflammatory tissue damage is responsible for morbidity and mortality in patients. The underlying mechanisms of matrix destruction in TB remain poorly understood but consideration of the lung extracellular matrix predicts that matrix metalloproteinases (MMPs) will play a central role, owing to their unique ability to degrade fibrillar collagens and other matrix components. Since we proposed the concept of a matrix degrading phenotype in TB a decade ago, diverse data implicating MMPs as key mediators in TB pathology have accumulated. We review the lines of investigation that have indicated a critical role for MMPs in TB pathogenesis, consider regulatory pathways driving MMPs and propose that inhibition of MMP activity is a realistic goal as adjunctive therapy to limit immunopathology in TB. ERS .
dc.languageeng
dc.publisherEuropean Respiratory Society
dc.relationEuropean Respiratory Journal
dc.relation1399-3003
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans
dc.subjectpathology
dc.subjectgenetics
dc.subjectmetabolism
dc.subjectphenotype
dc.subjectprotein expression
dc.subjectpathogenicity
dc.subjectmorbidity
dc.subjectreview
dc.subjectmortality
dc.subjectMycobacterium tuberculosis
dc.subjectTuberculosis
dc.subjectenzymology
dc.subjectinterstitial collagenase
dc.subjectMonocytes
dc.subjectlung tuberculosis
dc.subjectTuberculosis, Pulmonary
dc.subjectdoxycycline
dc.subjectimmunoglobulin G
dc.subjectenzyme activity
dc.subjectradiography
dc.subjectBCG vaccine
dc.subjectpathogenesis
dc.subjectenzyme inhibition
dc.subjectimmune reconstitution inflammatory syndrome
dc.subjectdexamethasone
dc.subjectprediction
dc.subjectLung
dc.subjectdrug antagonism
dc.subjectbacterial transmission
dc.subjectCD14 antigen
dc.subjectcollagen fibril
dc.subjectdrug targeting
dc.subjectenzyme degradation
dc.subjectExtracellular Matrix
dc.subjectgelatinase A
dc.subjectgelatinase B
dc.subjectGene Expression Profiling
dc.subjectImmunopathology
dc.subjectmatrilysin
dc.subjectmatrix metalloproteinase inhibitor
dc.subjectMatrix Metalloproteinases
dc.subjectneutrophil collagenase
dc.subjectstromelysin
dc.subjectstromelysin 2
dc.subjecttoll like receptor
dc.subjecttuberculous meningitis
dc.titleSeries "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in tuberculosis
dc.typeinfo:eu-repo/semantics/review


Este ítem pertenece a la siguiente institución